KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Royalty Pharma (RPRX) Free Cash Flow: 2018-2024

Historic Free Cash Flow for Royalty Pharma (RPRX) over the last 7 years, with Dec 2024 value amounting to $263.3 million.

  • Royalty Pharma's Free Cash Flow rose 47.19% to -$259.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $944.7 million, marking a year-over-year increase of 544.72%. This contributed to the annual value of $263.3 million for FY2024, which is 69.82% down from last year.
  • Royalty Pharma's Free Cash Flow amounted to $263.3 million in FY2024, which was down 69.82% from $872.3 million recorded in FY2023.
  • Royalty Pharma's 5-year Free Cash Flow high stood at $872.3 million for FY2023, and its period low was -$174.0 million during FY2021.
  • Moreover, its 3-year median value for Free Cash Flow was $402.3 million (2022), whereas its average is $512.6 million.
  • Per our database at Business Quant, Royalty Pharma's Free Cash Flow slumped by 173.10% in 2020 and then skyrocketed by 331.28% in 2022.
  • Royalty Pharma's Free Cash Flow (Yearly) stood at -$147.6 million in 2020, then fell by 17.85% to -$174.0 million in 2021, then soared by 331.28% to $402.3 million in 2022, then skyrocketed by 116.80% to $872.3 million in 2023, then tumbled by 69.82% to $263.3 million in 2024.